As per the recommendation of the International Expert Committee (IEC), individuals with HbA1c levels of 6.5% or more have a markedly increased risk of...
Four glucagon-like peptide-1 (GLP-1) receptor agonists have been known to reduce the risk of adverse cardiovascular events in type 2 diabetic patients but the...
Cagrilintide is a long-acting amylin analogue, and semaglutide 2•4 mg is a glucagon-like peptide-1 analogue. Both the drugs have been investigated as options for...
Although there is continuous update in treatment strategies for covid 19, antithrombotic management was observed to be a successful drug treatment of COVID-19. Justin...
Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospital admission for heart failure or death from cardiovascular complaints among patients with stable heart...
Previous cardiovascular outcome trials (CVOTs) suggest that greater benefit might be derived to Asians with newer classes of antihyperglycemic medications as compared to Whites....
